Athersys (ATHX)

Add to Watchlists
Create an Alert
2.73 +0.10  +3.80% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
ATHX Price Chart
View All Events

ATHX Events

Date Type Description
Mar 13 Misc Q4 2013 Athersys, Inc. Earnings Conference Call
Mar 13 Earnings Q4 2013 Athersys, Inc. Earnings Results. Estimate: -0.12.
Nov 14 Misc Athersys to Host Third Quarter 2013 Financial Results Call
Nov 14 Earnings Athersys Q3 2013 Release. Estimate: -0.12.
Aug 13 Misc Athersys Second Quarter 2013 Results Webcast
Aug 13 Earnings Second Quarter 2013 Financial Result. Estimate: -0.12.
Jun 18 Misc AGM Event for Athersys Inc
May 14 Misc Athersys First Quarter 2013 Results Webcast
May 14 Earnings Athersys to Host First Quarter 2013 Financial Results Call. Estimate: -0.10.
View All Performance Charts

ATHX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Athersys is up 24.66% over the last year vs S&P 500 Total Return up 23.54%, Cleveland BioLabs down 68.25%, and Osiris Therapeutics up 21.00%.

Get Quote for
Advertisement

Portfolio Strategies Featuring ATHX

Did Athersys make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ATHX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Ohio
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Athersys Inc. is a biopharmaceutical company that is focused in the field of regenerative medicine. It is engaged in the discovery and development of best-in-class therapies designed to extend and enhance the quality of human life.

Recent Quotes

Symbol Price Chg Chg % Market Cap
ATHX 2.73 +0.10 +3.80% 209.21M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.